Hofheinz, R. (2015). Improving patient outcomes with regorafenib for metastatic colorectal cancer - patient selection, dosing, patient education, prophylaxis, and management of adverse events. Oncology research and treatment, 38(6), . https://doi.org/10.1159/000382067
Chicago-Zitierstil (17. Ausg.)Hofheinz, Ralf-Dieter. "Improving Patient Outcomes with Regorafenib for Metastatic Colorectal Cancer - Patient Selection, Dosing, Patient Education, Prophylaxis, and Management of Adverse Events." Oncology Research and Treatment 38, no. 6 (2015). https://doi.org/10.1159/000382067.
MLA-Zitierstil (9. Ausg.)Hofheinz, Ralf-Dieter. "Improving Patient Outcomes with Regorafenib for Metastatic Colorectal Cancer - Patient Selection, Dosing, Patient Education, Prophylaxis, and Management of Adverse Events." Oncology Research and Treatment, vol. 38, no. 6, 2015, https://doi.org/10.1159/000382067.